MoMe Kardia Wireless Ambulatory ECG Monitoring and Detection System
Outpatient Cardiac Telemetry. 510(k) K160064, from Infobionic, Inc. (Lowell, MA). Product code QYX, class 2.
As of Nov 19, 2026, K160064 is an FDA 510(k) held by Infobionic, Inc., substantially equivalent on Mar 11, 2016 after 58 days, with no recalls tied to it in FDA's recall database.
- Review time: 58 days
- Recalls: 0
- Cited as a predicate by: 1 device
MoMe® Kardia is intended to be used for: 1. Patients who experience transient symptoms that may suggest cardiac arrhythmia. 2. Patients who require monitoring of effect of drugs to control ventricular rate in various atrial arrhythmias (e.g. atrial fibrillation) 3. Patients with symptoms that may be due to cardiac arrhythmias.
- Truvue Wireless Ambulatory Ecg Monitoring SystemK100155 · Biomedical Systems Corp. · Apr 20, 2010
- MoMe® ARC Wireless Ambulatory ECG Monitoring and Detection SystemK230265 · Infobionic, Inc. · Oct 6, 2023
- RhythmStar System (SL)K250793 · RhythMedix, LLC · Apr 21, 2026
- Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)K241179 · VivaQuant, Inc. · Jul 11, 2025
- SmartCardia 7L Platform (MCT)K240653 · Smartcardia SA · Oct 31, 2024
- Zio AT® device (A100A1001)K240029 · iRhythm Technologies, Inc. · Oct 21, 2024
- RhythmStar SystemK233584 · RhythMedix, LLC · Jul 8, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Jan 13, 2016
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1025
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files